Mycobacterium Citations List: June 2025

Literature Citations

1. Synthesis, Characterization, and Anti-Tb Application of Redox-active Ethyl Carbazate-derivatized Phenanthroline and Its Silver Complexes. Aluri, R., A. Natarajan, J. Kumari, D. Sriram, P.K. Samanta, A. Gangopadhyay, and K. Rangan. ACS Omega, 2025. ISI[001508703700001].
[WOS]. TB_06_2025.

2. In Vitro, Intracellular and In Vivo Synergy between Amoxicillin, Imipenem and Relebactam against Mycobacterium abscessus. Bitar, M., V. Le Moigne, J.L. Herrmann, M. Arthur, and J.L. Mainardi. Journal of Antimicrobial Chemotherapy, 2025. 80(6): p. 1560-1567. PMID[40177837].
[PubMed]. TB_06_2025.

3. Antifungal, Antimycobacterial, Protease and a‒amylase Inhibitory Activities of a Novel Serine Bifunctional Protease Inhibitor from Adenanthera pavonina L. Seeds. da Silva Gebara, R., M.S. da Silva, S.D. Calixto, T. Simão, A.E. Zeraik, E. Lassounskaia, M.F. Muzitano, J.H. Petretski, V.M. Gomes, and A. de Oliveira Carvalho. Probiotics and Antimicrobial Proteins, 2025. 17(3): p. 1320-1342. PMID[38117407].
[PubMed]. TB_06_2025.

4. Total Syntheses of Stereoisomeric Congeners of Rufomycin Natural Products Having Anti-Mycobacterial Activity. Fei, F., S. Lun, A. Pacheco, W.R. Bishai, and J.K. Sello. Organic Letters, 2025. 27(24): p. 6342-6348. PMID[40479592]. PMCID[PMC12186687].
[PubMed]. TB_06_2025.

5. Evaluation of the In Vitro Activity of Bedaquiline, Delamanid, and Clofazimine against Mycobacterium abscessus Complex and their Antibiofilm Potential. Kania, K., K. Wójcik, A. Skórkowska, and K. Klesiewicz. Pathogens, 2025. 14(6). PMID[40559590]. PMCID[PMC12195664].
[PubMed]. TB_06_2025.

6. Novel Quinazolinones Active against Multidrug-resistant Mycobacterium tuberculosis: Synthesis, Antimicrobial Evaluation, and In Silico Exploration of Penicillin-binding Protein 1a as a Potential Target. Kerda, M., D. Nawrot, P. Slechta, M. Domansky, A. Askari, H. Kamangar, O. Jandourek, K. Konecná, P. Paterova, I. Hlbocanová, M. Machácek, M. Mori, F. Meneghetti, M. Dolezal, J. Zitko, and G. Bouz. ChemMedChem, 2025: 2500147. ISI[001507990500001].
[WOS]. TB_06_2025.

7. One-for-all Photoactivatable Manganese-based Carbon Monoxide-releasing Molecules (CORMs) for Synergistic Therapy of Mycobacterial Infection. Lai, Y., L. Wang, H. Ma, Z. Chen, H. Wu, G. Wen, X. Wu, B. Yu, D. Li, G. Yuan, H. Huang, and P. Zhang. Journal of the American Chemical Society, 2025. 147(22): p. 19353-19363. PMID[40401605].
[PubMed]. TB_06_2025.

8. Efficacy of Novel Regimens Targeting Oxidative Phosphorylation in Mycobacterium tuberculosis. Li, D., L. Li, Y. Zhang, K. Cheng, W. Liang, E. Nuermberger, X. Qi, L. Fu, B. Wang, C. Yan, R. Xu, Y. Lu, and J. Xu. Antimicrobial Agents and Chemotherapy, 2025. 69(6): e0001925. PMID[40261049]. PMCID[PMC12135524].
[PubMed]. TB_06_2025.

9. Fused Ring Semicarbazones as Bioactive Agents: Structure, Hirshfeld Surface Analysis, Antimicrobial Activities, and Docking Studies. Mir, I.A., I. Singh, R.J. Butcher, and R. Sharma. ChemistrySelect, 2025. 10(22): e05522. ISI[001503240500001].
[WOS]. TB_06_2025.

10. Synthesis, Structural Characterization, and Antimicrobial Activity of Zn(cloxyquin)2: Towards Harnessing Zinc Intoxication and Immune Response Restoration to Combat Staphylococcus aureus and Mycobacterium tuberculosis. Mudarmah, K., N. Abeydeera, G. Chen, W. Jogadi, J.A. Krause, J.M. Budzik, and S.D. Huang. Dalton Transactions, 2025. 54(25): p. 9975-9983. PMID[40470632].
[PubMed]. TB_06_2025.

11. Discovery of 2,4,5-substituted Benzoxazole Derivatives as Pks13 Inhibitors Via the Scaffold Hopping Strategy. Obadawo, B.S., P.C. Bartolomeu Halicki, K.L. Becker, J.C. Seeliger, K.H. Rohde, and S.J. Sucheck. ACS Infect Dis, 2025. 11(6): p. 1460-1472. PMID[40338207].
[PubMed]. TB_06_2025.

12. Design and Evaluation of Quinoline-schiff Bases Targeting Mtb DNA Gyrase: In Vitro and Computational Approaches. Shaik, B.B., N. Tembe, A. Kajee, Z. Ngcobo, M. Ghai, V.A. Obakachi, S. Ghumran, V. Ntuli, M. Ornella, S. Nadigar, M.D. Bala, P. Singh, and R. Karpoormath. Chemistry Biodiversity, 2025. 22(6): e202402644. PMID[39876518].
[PubMed]. TB_06_2025.

13. A Network Pharmacology-based Approach to Understand the Mechanism of Action of Anti-Mycobacterial Activity of Acacia Nilotica: A Modelling and Experimental Study. Suresh, M., K.V. Sai, K. Mitra, R. Ravindran, and M. Doble. Molecular Diversity, 2025. 29(3): p. 2227-2242. PMID[39292406].
[PubMed]. TB_06_2025.

14. Green Synthesis of Cu Nanoparticles Using Biarum chaduchrum Leaf Extract and Their Efficacy against Multi-drug-resistant Mycobacterium tuberculosis. Zhang, X.G. and Z.Q. Ling. Chemical Papers, 2025. ISI[001495220600001].
[WOS]. TB_06_2025.

Patent Citations

15. New Anti-infective Tricyclic Spirolactams Compounds. Villemagne, B., R.C. Hartkoorn, N. Willand, B. Deprez, S. Tangara, P. Fischer, and C. Vigier. Patent. 2025. WO2024-EP851532025120200: 121 pp.
[Patent]. TB_06_2025.

16. Pyrazinamide-mimicking Small Molecules as Treatment for Tuberculosis and Their Preparation. Xue, F. Patent. 2025. WO2024-US583772025122558: 93 pp.
[Patent]. TB_06_2025.